The quest for vaccine-induced immune correlates of protection against tuberculosis.

BCG M72/AS01E correlates of protection systems vaccinology tuberculosis

Journal

Vaccine insights
ISSN: 2752-5422
Titre abrégé: Vaccine Insights
Pays: England
ID NLM: 9918557476006676

Informations de publication

Date de publication:
Jul 2022
Historique:
medline: 24 4 2023
pubmed: 24 4 2023
entrez: 24 04 2023
Statut: ppublish

Résumé

Immunization strategies against tuberculosis (TB) that confer better protection than neonatal vaccination with the 101-year-old Bacille Calmette-Guerin (BCG) are urgently needed to control the epidemic, but clinical development is hampered by a lack of established immune correlates of protection (CoPs). Two phase 2b clinical trials offer the first opportunity to discover human CoPs against TB. Adolescent BCG re-vaccination showed partial protection against

Identifiants

pubmed: 37091190
doi: 10.18609/vac/2022.027
pmc: PMC10117634
mid: NIHMS1865255
doi:

Types de publication

Journal Article

Langues

eng

Pagination

165-181

Subventions

Organisme : Bill & Melinda Gates Foundation
ID : INV-004813
Pays : United States
Organisme : Bill & Melinda Gates Foundation
ID : INV-027499
Pays : United States
Organisme : NIAID NIH HHS
ID : R37 AI054165
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI068635
Pays : United States

Références

PLoS Med. 2016 Oct 25;13(10):e1002152
pubmed: 27780211
Lancet Infect Dis. 2021 Mar;21(3):354-365
pubmed: 33508224
Nature. 2018 Aug;560(7720):644-648
pubmed: 30135583
Nature. 2020 Jan;577(7788):95-102
pubmed: 31894150
Clin Vaccine Immunol. 2017 Sep 5;24(9):
pubmed: 28701467
Nat Rev Dis Primers. 2016 Oct 27;2:16076
pubmed: 27784885
Nat Genet. 2019 Jan;51(1):138-150
pubmed: 30531872
Am J Respir Crit Care Med. 2017 Sep 1;196(5):638-648
pubmed: 28737960
Cytometry A. 2019 Jul;95(7):722-725
pubmed: 30919583
Proc Natl Acad Sci U S A. 2014 Oct 28;111(43):15520-5
pubmed: 25288770
Nat Genet. 2013 Oct;45(10):1176-82
pubmed: 23995134
Nat Commun. 2018 Dec 6;9(1):5208
pubmed: 30523338
J Infect Dis. 2022 May 16;225(10):1832-1840
pubmed: 33693706
Front Immunol. 2022 Mar 10;13:840225
pubmed: 35359957
Front Immunol. 2020 Jul 24;11:1452
pubmed: 32793199
Front Immunol. 2021 Feb 18;12:640168
pubmed: 33679802
J Clin Invest. 2018 May 1;128(5):1837-1851
pubmed: 29461976
Cytometry A. 2015 Feb;87(2):157-65
pubmed: 25515205
Am J Trop Med Hyg. 2019 Jul;101(1):164-179
pubmed: 31115304
Front Microbiol. 2021 Oct 06;12:750124
pubmed: 34691001
BMJ. 2014 Aug 05;349:g4643
pubmed: 25097193
Front Microbiol. 2020 Mar 11;11:332
pubmed: 32218774
Nat Med. 2018 Feb;24(2):130-143
pubmed: 29334373
Sci Transl Med. 2020 Oct 7;12(564):
pubmed: 33028708
Immunity. 2022 May 10;55(5):827-846.e10
pubmed: 35483355
JCI Insight. 2018 Oct 4;3(19):
pubmed: 30282828
Clin Infect Dis. 2012 Jun;54(11):1615-7
pubmed: 22437237
BMC Med. 2016 May 16;14:76
pubmed: 27183822
EBioMedicine. 2022 Feb;76:103839
pubmed: 35149285
Lancet Infect Dis. 2021 Jul;21(7):993-1003
pubmed: 33609457
PLoS Med. 2019 Apr 16;16(4):e1002781
pubmed: 30990820
Stat Med. 2016 Sep 20;35(21):3745-59
pubmed: 27037797
Clin Microbiol Rev. 1998 Jul;11(3):514-32
pubmed: 9665981
Proc Biol Sci. 2021 Jan 27;288(1943):20201635
pubmed: 33467995
Nat Rev Immunol. 2019 Sep;19(9):550-562
pubmed: 31114037
Nucleic Acids Res. 2018 Nov 16;46(20):10546-10562
pubmed: 30295871
Science. 2022 Jan 07;375(6576):43-50
pubmed: 34812653
Clin Infect Dis. 2014 Feb;58(4):470-80
pubmed: 24336911
PLoS Comput Biol. 2021 Aug 12;17(8):e1009224
pubmed: 34383739
N Engl J Med. 2019 Dec 19;381(25):2429-2439
pubmed: 31661198
Immunity. 2021 Aug 10;54(8):1636-1651
pubmed: 34348117
Clin Immunol. 2018 Nov;196:40-48
pubmed: 29960011
Sci Rep. 2020 May 25;10(1):8629
pubmed: 32451443
Nat Immunol. 2021 Dec;22(12):1515-1523
pubmed: 34811542
N Engl J Med. 2018 Jul 12;379(2):138-149
pubmed: 29996082
Nat Med. 2019 Feb;25(2):255-262
pubmed: 30664782
J Clin Invest. 2019 Sep 3;129(9):3482-3491
pubmed: 31478909
Commun Biol. 2020 Oct 9;3(1):563
pubmed: 33037320
Cell. 2016 Oct 6;167(2):433-443.e14
pubmed: 27667685
Vaccine. 2022 Mar 8;40(11):1534-1539
pubmed: 33863572
Clin Vaccine Immunol. 2010 Jul;17(7):1055-65
pubmed: 20463105
Epidemiol Methods. 2016 Dec;5(1):93-112
pubmed: 28154793
Front Immunol. 2019 Mar 22;10:527
pubmed: 30967866
BMJ Glob Health. 2022 Jan;7(1):
pubmed: 35039309
Clin Microbiol Rev. 2014 Jan;27(1):3-20
pubmed: 24396134
Vaccine. 2019 May 21;37(23):3022-3030
pubmed: 31040086
Nat Commun. 2016 Apr 12;7:11290
pubmed: 27068708
Vaccine. 2015 Jul 31;33(32):4025-34
pubmed: 26072017
J Immunol. 2014 Aug 15;193(4):1920-30
pubmed: 25024381
Clin Infect Dis. 2019 May 2;68(10):1713-1717
pubmed: 30202873
Biostatistics. 2022 Apr 13;23(2):541-557
pubmed: 32978622
Semin Immunol. 2020 Aug;50:101431
pubmed: 33279383
N Engl J Med. 2018 Oct 25;379(17):1621-1634
pubmed: 30280651
Lancet. 2016 Jun 4;387(10035):2312-2322
pubmed: 27017310
Tuberculosis (Edinb). 2015 May;95(3):352-7
pubmed: 25802031
Biometrics. 2018 Dec;74(4):1271-1281
pubmed: 29701875

Auteurs

Elisa Nemes (E)

South African Tuberculosis Vaccine Initiative, Division of Immunology, Department of Pathology and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.

Andrew Fiore-Gartland (A)

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.

Cesar Boggiano (C)

National Institute of Allergy and Infectious Diseases, National Institutes of Health.

Patricia D'Souza (P)

National Institute of Allergy and Infectious Diseases, National Institutes of Health.

Peter Gilbert (P)

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.

Ann Ginsberg (A)

Bill & Melinda Gates Foundation, Seattle, WA, USA.

Ollivier Hyrien (O)

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.

Karen Makar (K)

Bill & Melinda Gates Foundation, Seattle, WA, USA.

M Juliana McElrath (MJ)

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.

Lakshmi Ramachandra (L)

National Institute of Allergy and Infectious Diseases, National Institutes of Health.

Alexander C Schmidt (AC)

Bill & Melinda Gates Medical Research Institute, Cambridge, MA, USA.

Solmaz Shororbani (S)

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.

Justine Sunshine (J)

Bill & Melinda Gates Medical Research Institute, Cambridge, MA, USA.

Georgia Tomaras (G)

Duke Human Vaccine Institute, Duke University, Durham, NC, USA.

Wen-Han Yu (WH)

Bill & Melinda Gates Medical Research Institute, Cambridge, MA, USA.

Thomas J Scriba (TJ)

South African Tuberculosis Vaccine Initiative, Division of Immunology, Department of Pathology and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.

Nicole Frahm (N)

Bill & Melinda Gates Medical Research Institute, Cambridge, MA, USA.

Classifications MeSH